- Conditions
- Persistent Developmental Stuttering
- Interventions
- Pagoclone
- Drug
- Lead sponsor
- Pharmacology Research Institute
- Other
- Eligibility
- 18 Years to 65 Years
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Riverside, California
Source: ClinicalTrials.gov public record
Updated May 8, 2012 · Synced May 22, 2026, 1:42 AM EDT